Picture of Aytu Biopharma logo

AYTU — Aytu Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Aytu Bioscience Inc - Q2 Net Revenue $15.1 Million, Compared To $13.5 Million In Q1 2021

Feb 11 (Reuters) - Aytu BioScience Inc  AYTU.O :
    * AYTU BIOSCIENCE INC - Q2 NET REVENUE WAS $15.1 MILLION,
COMPARED
TO $13.5 MILLION IN Q1 2021
    * AYTU BIOSCIENCE INC - CASH, CASH EQUIVALENTS AND
RESTRICTED CASH
OF $62.3 MILLION ON DECEMBER 31, 2020
    * AYTU BIOSCIENCE INC - QTRLY LOSS PER SHARE $0.72

Source text for Eikon: [ID: https://bit.ly/3d59abS]
Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aytu Biopharma

See all news